Pancreaticoduodenectomy after neoadjuvant chemotherapy for gastric cancer invading the pancreatic head: A case report
CONCLUSION: We suggest that radical resection with PD after neoadjuvant chemotherapy plus trastuzumab is an option for locally advanced HER2-positive gastric cancer invading the pancreatic head in the absence of non-curative factors.PMID:33642827 | PMC:PMC7896433 | DOI:10.3748/wjg.v27.i6.534
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Masahiro Yura Kiminori Takano Kiyohiko Adachi Asuka Hara Keita Hayashi Yuki Tajima Yasushi Kaneko Yoichiro Ikoma Hiroto Fujisaki Akira Hirata Kumiko Hongo Kikuo Yo Kimiyasu Yoneyama Reiko Dehari Kazuo Koyanagi Motohito Nakagawa Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Cytology | Eloxatin | Esophagogastroduodenoscopy | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Herceptin | Laparoscopy | Liver | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Panendoscopy | Urology & Nephrology